Human papillomavirus knowledge and vaccine acceptability among male medical students in Saudi Arabia.
Human papillomavirus
acceptability
awareness
knowledge
vaccine
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
03 07 2021
03 07 2021
Historique:
pubmed:
2
2
2021
medline:
6
7
2021
entrez:
1
2
2021
Statut:
ppublish
Résumé
Human papillomavirus (HPV), the most common sexually transmitted infection worldwide, is responsible for a variety of cancers. HPV vaccines can help prevent this infection and its potentially devastating carcinogenic outcomes. Although the incidence of HPV-related oropharyngeal cancers among males is increasing, few studies have been published on HPV knowledge and vaccine acceptability among males. In this cross-sectional study, we assessed knowledge about HPV and the vaccine, as well as its acceptability, among third- and fourth-year male medical students in Jeddah, Saudi Arabia. Respondents were enrolled in any of the medical colleges in Jeddah from February to December 2018. A validated survey was used to collect information on HPV infection and vaccine knowledge and to ask questions assessing vaccine acceptability. HPV knowledge scores were created, and vaccine acceptability predictors were assessed with logistic regression. We collected data from 517 participants. Approximately 74% of the students had heard of HPV, with a mean knowledge score of 5.9 ± 4.6 out of 16; only 42% had heard of the HPV vaccine, with a mean knowledge score of 0.9 ± 1.6 out of 7. Among the respondents, 48.9% were interested in receiving the HPV vaccine. Although HPV infection and vaccine knowledge did not correlate with vaccine acceptability, those who had previously received the hepatitis B vaccine were more interested in receiving the HPV vaccine. In conclusion, male medical students had low HPV knowledge. Improving their HPV knowledge is important, as they are future health-care providers. The promotion of HPV vaccines in this potentially influential group is crucial for achieving effective disease prevention.
Identifiants
pubmed: 33522406
doi: 10.1080/21645515.2020.1856597
pmc: PMC8189128
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1968-1974Références
Trop Med Int Health. 2017 Jan;22(1):113-121
pubmed: 27754581
J Prim Care Community Health. 2017 Oct;8(4):349-362
pubmed: 29161946
J Cancer Educ. 2019 Apr;34(2):234-241
pubmed: 29063507
J Clin Oncol. 2018 Jan 20;36(3):262-267
pubmed: 29182497
Saudi Med J. 2009 Sep;30(9):1208-12
pubmed: 19750269
Prev Med Rep. 2017 Oct 10;8:169-176
pubmed: 29062681
Asian Pac J Cancer Prev. 2016;17(3):1135-9
pubmed: 27039738
Papillomavirus Res. 2017 Jun;3:142-148
pubmed: 28720448
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702
pubmed: 31415491
BMC Public Health. 2016 Mar 03;16:216
pubmed: 26936076
Vaccine. 2017 Jan 3;35(1):164-169
pubmed: 27887795
Sex Transm Infect. 2013 Nov;89(7):568-74
pubmed: 23828943
J Family Community Med. 2016 Sep-Dec;23(3):145-50
pubmed: 27625580
J Community Health. 2018 Dec;43(6):1192-1200
pubmed: 29922992
PLoS One. 2018 Dec 31;13(12):e0197648
pubmed: 30596646
BMC Infect Dis. 2014 May 24;14:290
pubmed: 24884734
Hum Vaccin Immunother. 2019;15(7-8):1656-1665
pubmed: 30648913
Papillomavirus Res. 2017 Dec;4:99-107
pubmed: 29179877
Eur J Obstet Gynecol Reprod Biol. 2015 Dec;195:77-82
pubmed: 26479435
Lancet. 2019 Aug 10;394(10197):497-509
pubmed: 31255301
Saudi Med J. 2014 Oct;35(10):1223-30
pubmed: 25316467
Vaccine. 2012 Nov 20;30 Suppl 5:F12-23
pubmed: 23199955
Prev Med. 2013 Jan;56(1):35-40
pubmed: 23142106
Health Educ Behav. 2018 Feb;45(1):68-76
pubmed: 28595454